Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $546.3 million.

  • United Therapeutics' Total Non-Current Liabilities fell 3745.13% to $546.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $546.3 million, marking a year-over-year decrease of 3745.13%. This contributed to the annual value of $738.1 million for FY2024, which is 3316.73% down from last year.
  • United Therapeutics' Total Non-Current Liabilities amounted to $546.3 million in Q3 2025, which was down 3745.13% from $527.1 million recorded in Q2 2025.
  • United Therapeutics' 5-year Total Non-Current Liabilities high stood at $1.2 billion for Q3 2023, and its period low was $527.1 million during Q2 2025.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $1.1 billion (2023), whereas its average is $998.2 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 1148.85% in 2023, then crashed by 4346.24% in 2025.
  • Over the past 5 years, United Therapeutics' Total Non-Current Liabilities (Quarter) stood at $1.1 billion in 2021, then grew by 3.42% to $1.1 billion in 2022, then decreased by 3.39% to $1.1 billion in 2023, then plummeted by 33.17% to $738.1 million in 2024, then dropped by 25.99% to $546.3 million in 2025.
  • Its Total Non-Current Liabilities stands at $546.3 million for Q3 2025, versus $527.1 million for Q2 2025 and $721.5 million for Q1 2025.